British drugmaker AstraZeneca Plc said on Thursday its vaccine was 76% effective in preventing symptomatic COVID-19 and that it has submitted the results to the US Data and Safety Monitoring Board.
The development comes after health officials publicly criticized the drugmaker for using "outdated information" to show how well the immunization worked.
AstraZeneca COVID-19 vaccine 76% effective in updated US trial results
By REUTERS
11/05/2024 01:08 PM
By REUTERS
11/05/2024 12:33 PM
By REUTERS
11/05/2024 12:31 PM
By REUTERS
11/05/2024 12:22 PM
By AVI ASHKENAZI
11/05/2024 11:34 AM
By REUTERS
11/05/2024 11:15 AM
By REUTERS
11/05/2024 10:54 AM
By REUTERS
11/05/2024 10:14 AM
By REUTERS
11/05/2024 01:17 AM
By REUTERS
11/05/2024 01:02 AM